Purdue Frederick pricing suit "no-fault" settlement approved over pharmacy advocate objections.
PURDUE FREDERICK PRICING SUIT $1.4 MIL. SETTLEMENT APPROVED Nov. 29 by Chicago federal court Judge Charles Kocoras. The decision followed a Nov. 21 hearing at which pharmacy activists testified against the settlement because of fears that it would set a precedent in other discriminatory pricing suits for monetary settlement without admission of wrongdoing.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth